Note: Not all CAS servers will download the new OAB at the exact same time.
注意：并不是所有的CAS服务器会在精确的时间差内下载新的OAB。
OAB is more common than osteoarthritis or diabetes(1,2) and is estimated to affect 16-17% of the population in the U.
OAB较骨关节病和糖尿病更为常见，据评估在美国和西欧的16~17%人群中流行。
However, many OAB patients discontinue medication due to insufficient relief of symptoms or intolerable side effects that can include dry mouth, dry eyes, constipation and headache.
但是，许多病人由于症状缓解不明显或难以耐受副反应(包括口、眼干燥，便秘以及头痛)而停止了用药。
OAB is characterized by feelings of urgency to urinate, with or without incontinence, and is usually accompanied by increased urination frequency and nocturia (excessive urination at night).
OAB定义为尿急伴有或无尿失禁，常有尿频和夜尿(夜间排尿次数增多)。
Conclusions Solifenacin vesicare is a safer and more effective drug over tolterodine for the treatment of patients with OAB, and it could be served as a drug of first choice for treating OAB.
结论琥珀酸索利那新治疗OAB较托特罗定有更好的效果和更高的安全性，琥珀酸索利那新将可能成为治疗OAB的首选药物。
Currently, the pathogenesis of OAB has not been elucidated, and neither its diagnostic criteria is uniform nor the decision of its therapy as well as therapeutic efficacy comes to reach agreement.
目前该病的发病机制尚未阐明，诊断标准也不统一，治疗方案和疗效判定也存在争议。
Currently, the pathogenesis of OAB has not been elucidated, and neither its diagnostic criteria is uniform nor the decision of its therapy as well as therapeutic efficacy comes to reach agreement.
目前该病的发病机制尚未阐明，诊断标准也不统一，治疗方案和疗效判定也存在争议。
应用推荐